Anne Brunke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anne Brunke has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Axel Hamprecht
Carl von Ossietzky University Oldenburg
1 shared publication - Georg Plum
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50923 Cologne, Germany
1 shared publication - Jacques F. Meis
Department of Medical Microbiology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
1 shared publication - Janina Noster
Abteilung Mikrobiologie, Universität Osnabrück, Osnabrück, Germany
1 shared publication - Janko Sattler
Department of Machine Learning and Systems Biology, Max Planck Institute of Biochemistry, Martinsried, Germany
1 shared publication - Oliver Kurzai
Institute for Hygiene and Microbiology, University of Würzburg
1 shared publication
Latest Publications
- Open Access
- 22 February 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (2) , 154
Comparison of Two Commercially Available qPCR Kits for the Detection of Candida auris
Candida auris is an emerging pathogen with resistance to many commonly used antifungal agents. Infections with C. auris require rapid and reliable detection methods to initiate successful medical treatment and contain hospital outbreaks. Conventional identification methods are prone to errors and can lead to misidentifications. PCR-based assays, in turn, can provide reliable results with low turnaround times. However, only limited data are available on the performance of commercially available assays for C. auris detection. In the present study, the two commercially available PCR assays AurisID (OLM, Newcastle Upon Tyne, UK) and Fungiplex Candida Auris RUO Real-Time PCR (Bruker, Bremen, Germany) were challenged with 29 C. auris isolates from all five clades and eight other Candida species as controls. AurisID reliably detected C. auris with a limit of detection (LoD) of 1 genome copies/reaction. However, false positive results were obtained with high DNA amounts of the closely related species C. haemulonii, C. duobushaemulonii and C. pseudohaemulonii. The Fungiplex Candida Auris RUO Real-Time PCR kit detected C. auris with an LoD of 9 copies/reaction. No false positive results were obtained with this assay. In addition, C. auris could also be detected in human blood samples spiked with pure fungal cultures by both kits. In summary, both kits could detect C. auris-DNA at low DNA concentrations but differed slightly in their limits of detection and specificity.
- 22 February 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (2) , 154
Open AccessComparison of Two Commercially Available qPCR Kits for the Detection of Candida auris
Candida auris is an emerging pathogen with resistance to many commonly used antifungal agents. Infections with C. auris require rapid and reliable detection methods to initiate successful medical treatment and contain hospital outbreaks. Conventional identification methods are prone to errors and can lead to misidentifications. PCR-based assays, in turn, can provide reliable results with low turnaround times. However, only limited data are available on the performance of commercially available assays for C. auris detection. In the present study, the two commercially available PCR assays AurisID (OLM, Newcastle Upon Tyne, UK) and Fungiplex Candida Auris RUO Real-Time PCR (Bruker, Bremen, Germany) were challenged with 29 C. auris isolates from all five clades and eight other Candida species as controls. AurisID reliably detected C. auris with a limit of detection (LoD) of 1 genome copies/reaction. However, false positive results were obtained with high DNA amounts of the closely related species C. haemulonii, C. duobushaemulonii and C. pseudohaemulonii. The Fungiplex Candida Auris RUO Real-Time PCR kit detected C. auris with an LoD of 9 copies/reaction. No false positive results were obtained with this assay. In addition, C. auris could also be detected in human blood samples spiked with pure fungal cultures by both kits. In summary, both kits could detect C. auris-DNA at low DNA concentrations but differed slightly in their limits of detection and specificity.